OTC Finished Formulation Process Validation & Cleaning Validation Guide
Introducing the three stages of process validation and calculating cleaning validation residue limits using toxicology thresholds (ADE/PDE).
Under 21 CFR 211, drug manufacturing must undergo systematic qualification. Process Validation (PV) runs through 3 stages: Stage 1 (Process Design/QbD); Stage 2 (Process Qualification, including facility qualification IQ/OQ/PQ and 3 consecutive commercial PV batches); and Stage 3 (Continued Process Verification/CPV). Cleaning validation requires calculating Maximum Allowable Carryover (MACO) based on toxicity.
Toxicological Calculations for Cleaning Validation
When different products (e.g., creams, soaps) are manufactured in the same vessel, cleaning effectiveness must be proved by chemical assays (HPLC swab/rinse testing).
- MACO parameters: coarse methods like 10 ppm or 1/1000th dose are deprecated
- Toxicology PDE/ADE: calculating cleaning targets based on the active ingredient’s Permitted Daily Exposure
- Swab recovery qualification: testing recovery rates of swabs from representative surfaces (e.g., stainless steel)
FAQ
Are 3 consecutive batches mandatory for process validation?+
Under updated FDA guidelines, "3 consecutive batches" is no longer a strict legal limit but remains the industry baseline. Manufacturers must use statistical tools (e.g., Cpk) to prove variability is controlled. Highly variable processes may require 5 to 10 batches.
Next steps
If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.
